US Launches Investigation into German Drug Pricing Policies, Setting Stage for Potential Trade Sanctions
The United States has opened a formal investigation into Germany's pharmaceutical pricing policies, potentially paving the way for new tariffs. The probe reflects ongoing transatlantic trade tensions over drug costs.